Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer - Scancell

Home
About Us
Science
- Active Immunotherapies
- Antibodies
Our Pipeline
News
Investors
Publications
Contact Us
- Find a trial
- Become an Investigator

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell is focused on developing novel immunotherapies for the treatment of cancer and was founded in 1996 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.

Search for:

About Us
Leadership Team
Science
Our Pipeline
News
Contact Us
Find a Trial
Become an Investigator

ACTIVE IMMUNOTHERAPY

ImmunoBody^®
Moditope^®

ANTIBODIES

GlyMab^®
AvidiMab^®

Investors
Company Profile
Advisors
Corporate Governance
Documents & Presentations
Share Information
Financial Information

Copyright © 2026 Scancell | Website Designed & Developed by Identity Creative | Privacy & Cookie Policy